Showing results (181-190 of 440) with videos related to
Sort By:
Pageof 44
The American Journal of Cardiology|September 19, 2024
Meta-Analysis of Physiology-Guided Complete or Culprit Lesion-Only Percutaneous Coronary Interventions in Myocardial InfarctionSahib Singh, Udaya S Tantry, Kevin Bliden, et al.Thrombosis and Haemostasis|January 16, 2020
Effect of Smoking Cessation on the Pharmacokinetics and Pharmacodynamics of Clopidogrel after PCI: The Smoking Cessation Paradox StudyBogumił Ramotowski, Paul A Gurbel, Udaya Tantry, et al.Arquivos Brasileiros De Cardiologia|August 22, 2019
High Residual Platelet Reactivity during Aspirin Therapy in Patients with Non-St Segment Elevation Acute Coronary Syndrome: Comparison Between Initial and Late PhasesMarianna Deway Andrade Dracoulakis, Paul Gurbel, Marco Cattaneo, et al.American Heart Journal|March 12, 2011
The relation between CYP2C19 genotype and phenotype in stented patients on maintenance dual antiplatelet therapyPaul A Gurbel, Alan R Shuldiner, Kevin P Bliden, et al.Magnesium Research|December 1, 1993
Effect of magnesium sulphate infusion on ex vivo platelet aggregation in swineW R Herzog, D Atar, P A Gurbel, et al.Platelets|April 10, 2010
Hypercoagulability, platelet function, inflammation and coronary artery disease acuity: results of the Thrombotic RIsk Progression (TRIP) studyUdaya S Tantry, Kevin P Bliden, Thomas A Suarez, et al.Platelets|October 13, 2011
Clinical efficacy and safety of intracoronary vs. intravenous abciximab administration in STEMI patients undergoing primary percutaneous coronary intervention: a meta-analysis of randomized trialsEliano Pio Navarese, Marek Kozinski, Karolina Obonska, et al.Platelets|February 24, 2009
The link between heightened thrombogenicity and inflammation: pre-procedure characterization of the patient at high risk for recurrent events after stentingPaul A Gurbel, Kevin P Bliden, Rolf P Kreutz, et al.Journal of the American College of Cardiology|February 13, 2007
Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate?Kevin P Bliden, Joseph DiChiara, Udaya S Tantry, et al.Cardiology|June 26, 2001
Platelet function and fibrinolytic agents: two sides of a coin?K P Callahan, A I Malinin, P A Gurbel, et al.Pageof 44